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Abstract
Human rhinovirus infection (HRVI) plays an important role in asthma exacerbations and is
thought to be involved in asthma development during early childhood. We hypothesized that
HRVI causes differential DNA methylation and subsequently differential mRNA expression
in epithelial cells of children with asthma. Primary nasal epithelial cells from children with
(n = 10) and without (n = 10) asthma were cultivated up to passage two and infected with
Rhinovirus-16 (RV-16). HRVI-induced genome-wide differences of DNA methylation in
asthmatics (vs. controls) and resulting mRNA expression were analyzed by the Human-
Methylation450 BeadChip Kit (Illumina) and RNA sequencing. These results were further
verified by pyrosequencing and quantitative PCR, respectively. 471 CpGs belonging to 268
genes were identified to have HRVI-induced asthma-specifically modified DNA methylation
and mRNA expression. A minimum-change criteria was applied to restrict assessment of
genes with changes in DNA methylation and mRNA expression of at least 3% and least 0.1
reads/kb per million mapped reads, respectively. Using this approach we identified 16
CpGs, including HLA-B-associated transcript 3 (BAT3) and Neuraminidase 1 (NEU1),
involved in host immune response against HRVI. HRVI in nasal epithelial cells leads to spe-
cific modifications of DNA methylation with altered mRNA expression in children with
asthma. The HRVI-induced alterations in DNA methylation occurred in genes involved in the
host immune response against viral infections and asthma pathogenesis. The findings of
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our pilot study may partially explain how HRVI contribute to the persistence and progression
of asthma, and aid to identify possible new therapeutic targets. The promising findings of
this pilot study would benefit from replication in a larger cohort.
Introduction
Asthma is the most common chronic disease affecting children, with an increasing prevalence
particularly in westernized countries since the latter half of the 20th century [1–3]. The patho-
physiological changes underlying asthma development are complex, comprising airway
inflammation combined with excessive airway smooth muscle growth, alterations in patterns
of vascularization and innervation, as well as changes of the epithelial-mesenchymal trophic
unit [4]. Known risk factors for asthma development include a family history of atopic disease,
passive smoke exposure, and allergic sensitization to food and/or inhaled allergens.
The theory of early viral infections in the development of asthma has been well established.
While Respiratory Syncytial Virus was initially considered to be the most important viral path-
ogen risk-factor in asthma development, Human Rhinovirus (HRV) has recently been recog-
nized as a major etiologic factor in wheezing illnesses with a significant link to asthma
development during childhood [5, 6].
HRV is a picornavirus, a single-stranded RNA virus belonging to the enterovirus genus,
which consists of more than 160 forms, classified into A, B and C [7]. HRV-A and -C have
been linked to lower respiratory tract infections (LRTIs) with increased morbidity in affected
children. Individuals with atopic asthma suffer from more frequent symptomatic respiratory
tract infections (RTI) and have more severe and longer-lasting respiratory symptoms following
a HRV infection (HRVI) [8].
Evidence of HRVI involvement in the origin of asthma first emerged from a Finnish study
whereby 60% of infants in this cohort who presented with a HRVI and wheezing in the first 2
years of life, went on to develop asthma by age 5 [9]. Similarly, in children with a positive fam-
ily history of atopy, HRV-induced wheezing during the first 3 years of life was associated with
a nearly 10-fold increased risk for developing asthma by age 6 [5]. Other studies have demon-
strated that HRV-induced wheezing episodes are positively associated with asthma risk [6, 10,
11]. In addition, HRV has been postulated to trigger acute wheezing episodes and asthma exac-
erbations. HRV is frequently isolated in the upper airways of children and adolescents during
asthma exacerbations [12]. Moreover, children with asthma have higher antibody titers spe-
cific to HRV-A, and to a lesser extent HRV-B, compared to non-asthmatic controls [13].
Taken together, HRV is believed to play a pivotal role in asthma development and deterio-
ration. However, the association of HRVI with asthma does not allude to a causal relationship.
It remains unknown whether asthma development and/or deterioration is a direct conse-
quence of viral infection in early life, or simply to host predisposition to disease development,
or a combination of both.
We hypothesize that HRVIs lead to epigenetic modifications of immunoregulatory genes in
the airway epithelium. Epigenetic modifications refer to genetic alterations that affect gene
expression without affecting the genomic mechanisms which register, mark, or perpetuate
gene activity states. DNA methylation is one of the main epigenetic mechanisms occurs and
involves the addition of a methyl group to the 50 position of a cytosine followed by guanine
(CpG dinucleotide) [14].
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In this study, we aimed to characterize the impact of HRVI on epigenetic modifications,
specifically DNA methylation, in genome-wide methylation arrays of the primary human nasal
epithelial cells (representative of the airway epithelium) of children with doctor-diagnosed
asthma as participants of the ALLIANCE cohort and healthy children without asthma (con-
trols). We hypothesized that HRVI induces a differential pattern of DNA methylation (RV-
infection induced differential DNA methylation, RIDM) and mRNA expression (RV-infection
induced differential mRNA expression, RIRE) in nasal epithelial cells of children with and with-
out asthma. Asthma-specific modifications could play an important role in the host-pathogen-
interaction in viral infections and in the development and progression of asthma.
Materials and methods
Study population
From January 2014 to February 2015, in Lu¨beck, Germany, 10 children with doctor-diagnosed
asthma and 10 healthy children without asthma were recruited into the study.
The study design and analysis strategy is displayed in Fig 1. The study was approved by the
Ethics Committee of the University of Lu¨beck (Vote 12–215, December 18th, 2012) and
informed written consent was obtained from the parents or legal guardians of all children par-
ticipating in this study. This study is registered at clinicaltrials.gov (NCT02496468). All sub-
jects had to be aged 6 to 18 years, be born from a full-term pregnancy (�37 weeks), and have
Fig 1. Study design and data analysis strategy.
https://doi.org/10.1371/journal.pone.0205275.g001
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an active/passive understanding of German. For children with asthma recruitment into the
ALLIANCE cohort included additionally meeting the following inclusion criteria: an asthma
diagnosis based on the 2014 Global Initiative for Asthma (GINA) guidelines [15] which rec-
ommended a history of characteristic symptom patterns (i.e. wheezing, shortness of breath,
chest tightness, and cough) and document evidence of airflow limitation, bronchodilator
reversibility testing, or a positive bronchial provocation. As a baseline assessment, all eligible
subjects underwent a physical examination, completed lung function (forced expiratory vol-
ume in 1 second [FEV1] and forced vital capacity [FVC]) and fractional exhaled nitric oxide
(FeNO) (marker of airway inflammation) assessments, provided history of doctor-diagnosed
allergic rhinitis and allergic dermatitis, completed questionnaires, and provided a blood sam-
ple for routine clinical analysis. Allergic sensitization at baseline was recorded, defined as at
least one specific IgE against inhaled or ingested allergens above a level of> 0.7 kU/L (Euro-
LINE, EuroImmun, Lu¨beck, Germany). Steroid use at baseline was recorded, defined as no use
of inhaled corticosteroids (ICS) for 4 weeks prior to the clinic visit. Individuals with fever
(>38.5˚C) or signs of upper respiratory tract infections (URTIs) or LRTIs in the 2 weeks prior
to the clinic visit were excluded from the study.
Primary nasal epithelial cell culture
Nasal brushings were performed on each subject using a 3 mm IDB-G brush (Top Caredent,
Zu¨rich, Switzerland). Primary human nasal epithelial cells were then cultivated on 6 well plates
(Sarstedt, Nu¨mbrecht, Germany) pre-coated with collagen (1:50 PureCol, Advances Bio
Matrix, Carlsbad, USA) and supplemented with BEGM (Lonza, Basel, Switzerland).
HRVI was performed in vitro, by exposing 3x105 nasal epithelial cells (passage 2) from each
subject to an infection with Rhinovirus-16 (RV-16) (virus stock: 9x109 RV-16/mL in 10 mM
EDTA, 1 mM Tris, HeLa origin, sucrose gradient purified) in 1 mL BEGM, at a multiplicity of
infection (MOI) of 10. The nasal epithelial cells were incubated for 1 hour at room tempera-
ture, agitated every 5 minutes. 1 mL of BEGM was then added to the culture. This experiment
was duplicated as a MOCK-infection (virus-free) experiment with 3x105 nasal epithelial cells
exposed to buffer only without RV-16 (10 mM EDTA, 1 mM Tris). Epithelial cells were har-
vested 48 hours post infection using trypsin-EDTA (PAA, L11-003) and stored in 350 μl
RLT-Buffer (Qiagen, Hilden, Germany) at -70˚C prior to DNA and RNA extraction.
Successful HRVI was confirmed by the positive detection of interleukin-6 (IL6) and 8 (IL8)
expression in human nasal epithelial cell culture supernatants, using a bead ELISA Bio-Plex
Pro™ Human Chemokine 40-plex Assay (BioRad, Hercules, USA) with a Bio-Plex MAGPIX
Multiplex Reader (BioRad, Hercules, USA), as per manufacturer’s specifications.
Genome wide analysis of DNA methylation and mRNA expression
DNA and RNA were isolated from HRVI and MOCK-infected primary nasal epithelial cells
from children with and without asthma, using the AllPrep DNA/RNA/Protein Mini Kit (Qia-
gen, Hilden, Germany). DNA concentration was measured using the FLUOstar Omega-Sys-
tem (BMG-Labtech, Ortenberg, Germany). The RNA concentration and quality was
quantified with the Agilent RNA6000 Nano Chip Kit (Agilent, Santa Clara, USA).
DNA methylation was quantified using a HumanMethylation450 BeadChip Kit and mRNA
expression was quantified using RNA sequencing measurements. These assays were carried
out at the Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, fol-
lowing the manufacturer’s protocols.
Genome-wide analysis of loci specific DNA methylation was performed using 500 ng bisul-
fite-converted genomic DNA (EZ DNA methylation Kit, Zymo Research, D5001) using a
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HumanMethylation450 BeadChip Kit (Illumina, San Diego, USA). The chip visualisation was
performed with the HiScanSQ System (Illumina, San Diego, USA). β-values were calculated as
the fraction signal from the methylated beads over the sum of methylated and unmethylated
bead signals. β-values were Illumina normalized (Partek Genomic Suite 6.6, Partek, Chester-
field, USA). The CpG to gene mapping was conducted following Illumina specifications.
For RNA sequencing, 1000 ng of total RNA (RNA integrity number (RIN) >8) were
applied using a HiSeq PE Cluster Kit v4, cBot (Illumina, San Diego, USA), and a HiSeq SBS
Kit v4 (Illumina, San Diego, USA) and the HiSeq2500 System (Illumina, San Diego, USA).
The RNA sequencing reads were further processed with Partek Flow (Software Partek Flow
4.0, Partek, Chesterfield, USA). The average of total reads (Read Length = 120 bp) in a sample
was 28.7x106 reads with an average quality score of 36.2. Reads with a quality score < 20 were
removed. Reads were aligned to the human genome using the GSNAP algorithm (version 3)
and aligned 95.1% of the reads in average in a cell culture sample. Before the alignment of the
reads adapter sequences were removed.
RNA expression analysis was performed after reads per kilobase per million mapped reads
(RPKM) normalisation.
Pyrosequencing
The findings of DNA methylation quantification, namely CpG cg24890294, were verified
using pyrosequencing. Bisulfite conversion of genomic DNA was achieved with the EpiTect
Bisulfit Kit (input 200 ng genomic DNA, Qiagen, Hilden, Germany). Primers for amplification
(F: AGATGAATGTAAAAGAGTTTAAGGAGTAT, R: CCCAACCCCCTTACTATATTCCTA-bio)
and sequencing (S: AGTATATTGTTGTTTTTGTTAGT) were designed using PyroMark Assay
Design 2.0 software (Qiagen, Hilden, Germany). Amplification of the sequencing template
region for pyrosequencing was performed using a PyroMark PCR Kit 200 (Qiagen, Hilden,
Germany) under recommended PCR conditions and on 100 ng of bisulfite-converted DNA
per sample. Sequencing of the specific template was performed using a Q24 Pyromark System
(Qiagen, Hilden, Germany) with PyroMark Gold Reagents 5 x 24 Kit (Qiagen, Hilden, Ger-
many). The verification of further CpGs was not performed due to limited DNA samples.
Quantitative PCR
The results of RNA sequencing (as described above) were verified by quantitative PCR (qPCR).
Four genes were selected for quantification: IL6, IL8, HLA-B-associated transcript 3 (BAT3)
and neuraminidase 1 (NEU1). Expression of IL6, IL8, BAT3 and NEU1 was quantified by com-
plementary DNA (cDNA) analysis using the 7900HT Fast Real-Time PCR System (Thermo-
Fisher Scientific, Waltham, USA) with Taqman Universal PCR Master Mix (Life Technologies
Carlsbad, USA), and PrimeTimeMini qPCR Assays (IDT, BAT3 Hs.PT.58.22627504, IL6 Hs.
PT.58.39866843.g, IL8 Hs.PT.58.38869678.g, NEU1 Hs.PT.58.19158252.5, and the reference
genes REEP5 Hs.PT.58.39651019, RPS18 Hs.PT.58.14390640, Coralville, USA). The conversion
of 300 ng RNA into cDNA was performed using a SuperScriptVILO cDNA Synthesis Kit (Invi-
trogen, Carlsbad, USA) and a thermocycler (Peqlab, peqstar 2x Thermocycler, Erlangen,
Germany).
Data analysis
Prior to the analysis, the difference between HRVI and MOCK infection (Δ = HRVI-MOCK)
was calculated for all CpG β-values and all RPKM mRNA expression values for each donor.
The resulting difference of DNA methylation (RIDM) and mRNA expression (RIRE) was
assessed. For both datasets, an analysis of variance (ANOVA) (Software Partek Genomic Suite
Rhinovirus infections in children with asthma
PLOS ONE | https://doi.org/10.1371/journal.pone.0205275 November 28, 2018 5 / 18
6.6, Partek, Chesterfield, USA) was performed to detect asthma-specific RIDM CpGs as well as
asthma-specific RIRE in children with asthma compared with children without asthma (differ-
ences indicated by a p-value of< 0.05). These findings were further analysed to identify those
genes were both, RIDM and RIRE, showed differences in asthma vs. control. Minimum-
change thresholds were applied to filter the findings (3% for DNA methylation and 0.1 RPKM
for mRNA expression), which were subjected to verification by pyrosequencing (DNA methyl-
ation) and qPCR (mRNA expression. Resulting CpGs were checked for known single nucleo-
tide polymorphisms (SNPs). Linear models were used to analyze the correlation between
modified DNA methylation and corresponding mRNA expression values. The resulting r2 val-
ues described the strength of the correlation (fit quality). For the statistical analysis of qPCR,
pyrosequencing, and bead ELISAs a non-parametric t-test (Mann-Whitney test) was applied.
For the discrimination of allergic sensitization and steroid use Fisher’s exact test was used. The
analysis of viral-modified cellular process pathways was performed using the software tool
GseaPreranked (gene set enrichment analysis, GSEA, Broad Institute, v2.2.3, Boston, USA),
the weighted enrichment statistic setting and the Kegg database (v5.2). Pathways with� 1000
or� 5 affected genes were excluded from the analyses.
Comparison of our results with the Inner City Asthma Consortium
The results obtained in our study were verified against those of the Inner City Asthma Consor-
tium [16]. The β-values of the MOCK-infected nasal epithelial cells from children with and
without asthma in our study were analysed as described above, and the asthma-specific CpG
methylations were compared to those reported in the Inner City Asthma Consortium. The
analysis was focused on single CpGs with the most pronounced DNA methylation changes
reported by Yang et al and their method validation CpG set [16].
Results
Study population
Nasal epithelial cells were collected from 10 children with asthma (5 boys, mean age 11.6
years) and 10 children without asthma (5 boys, mean age 11.6 years), all subjects of the ALLI-
ANCE cohort. As expected, a greater number of children with asthma had allergic sensitization
and reported steroid use, when compared to children without asthma. In contrast, no differ-
ences were found in forced expiratory volume in 1 second (FEV1) % predicted, FEV1/ FVC, or
NO (Table 1).
Model validation
The in vitro model of simulated HRVI in this study, with the infection of human nasal epithe-
lial cells with RV-16 (RV-16 virus stock: 9x109 RV-16/mL in 10 mM EDTA, 1 mM Tris, HeLa
origin, sucrose gradient purified) demonstrated increased IL-6 and IL-8 protein and mRNA
expression in the HRVI-cell cultures compared with MOCK-infected cell cultures (Fig 2).
RIDM and RIRE are significantly different in asthmatic nasal epithelial
cells
The analysis of genome-wide methylation patterns after HRVI identified 27,517 CpGs, which
showed significant RIDM (p-value <0.05, Fig 3A). The largest RIDM was detected for
cg00063477, EIF1AY (+41%) and cg00061679, DAZ1, DAZ4 (-53%) when asthma was com-
pared with controls. In 10,498 CpGs RIDM was increased, while in 15,155 CpGs, RIDM
showed a decrease (asthma vs. controls). These 27,517 viral-modified CpGs were then
Rhinovirus infections in children with asthma
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classified into 11 different functional groups by GseaPreranked analysis, of which 10 had
decreased RIDM and 1 pathway had increased RIDM (Table 2).
At the mRNA level, 1,303 mRNAs were identified to display RIRE in asthma, when com-
pared to controls (Fig 3B). There were 512 genes with increased expression and 791 genes with
decreased expression after HRVI (asthma vs. control).
After matching the result lists of RIDM and RIRE, 471 CpGs remained which were signifi-
cantly different between asthmatics and controls, comprising in total 268 genes. RIDM and
RIRE are displayed in Fig 3C. Following minimum-change-filtering criteria, the number of
possible targets was focused to 16 CpGs (Fig 4, RIDM and RIRE given in S1 and S2 Tables).
The genomic position and function of the affected genes are listed in Table 3. Of these 16
modified CpGs, 4 were localized on chromosome 6 (chr6p21.32-p21.33), and 2 of the 16 iden-
tified CpGs, BAT3 and NEU1, showed a correlation between DNA and mRNA values, and
were previously investigated in the context of asthma and HRVI.
Table 1. Characteristics of the study population.
Control (N = 10) Asthma (N = 10) p value
Males (n) 5 5
Atopy (n) 0 9 0.0001
Steroid naive (n) 10 2 0.0055��
Allergic sensitisation (n) 1 8 0.0055��
Doctors Diagnosis of AR 0 4 0.0010��
Doctors Diagnosis of AD 0 3 0.0035��
Mean SD Mean SD
Age (years) 11.6 (8–15) 2.2 11.6 (8–15) 2.5 0.9705�
Weight (kg) 44.9 (28–68) 10.8 43.9 (29–66) 13.24 0.9097�
FEV1% predicted 96.5 11.8 100.2 9.7 0.4055�
FEV1/FVC (%) 98.36 14.5 90.2 13.3 0.9607�
NO (ppb) 16. 8 6.7 32.8 33.2 0.8063�
AR–allergic rhinitis, AD–atopic dermatitis, SD–standard deviation, FEV1 –forced expiratory volume in 1 second, FVC–forced vital capacity, NO- Nitric Oxide
� nonparametric t-test (Mann-Whitney test)
��Fisher’s exact test
https://doi.org/10.1371/journal.pone.0205275.t001
Fig 2. Increased expression of IL6 and IL8 in human nasal epithelial cells after HRVI. IL6 (A) and IL8 (B) protein
(supernatant concentration) and mRNA expression (qPCR, ΔCT, RPS18 as reference gene) were increased in human
nasal epithelial cells after HRVI (n = 20, Mann-Whitney test). mRNA expression was verified by RNA sequencing
(RPKM).
https://doi.org/10.1371/journal.pone.0205275.g002
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The CpG cg24890294 is localized in exon 3 of the HLA-B-associated transcript 3 (BAT3)
gene. The median percentage difference of DNA methylation (ΔHRVI-MOCK) after HRVI
between asthmatics and controls was -3.4% (Fig 5A). This finding was confirmed by pyrose-
quencing (Fig 5B). Furthermore, we detected decreased mRNA expression after HRVI in
asthma compared to control subjects (-0.62 RPKM) using RNA sequencing and qPCR (Fig 5C
and 5D). The correlation between HRVI-induced modification of DNA methylation and the
change in mRNA expression (Fig 5E) suggests the possibility that cg24890294 is involved in
the regulation of BAT3 mRNA expression.
Further, two CpGs in BAT3 g (cg14661811 and cg26710858) were also demonstrated to
have differential DNA methylation in asthma compared with control (Table 4). A multi-facto-
rial analysis of cg14661811, cg26710858, and cg24890294 was carried out to determine the
influence of these CpGs on BAT3 mRNA expression, and only a model composed of
cg24890294 and cg14661811 correlated to the mRNA expression values of BAT3 (Fig 6).
The second gene with significant RIDM and RIRE in asthmatics vs. controls was Neur-
aminidase 1 (NEU1). Similar to what we observed in BAT3, NEU1 had decreased DNA meth-
ylation in cg05550349 (exon 3) after HRVI in children with asthma compared to controls. The
mean value of RIDM (asthma vs. control) in this CpG was -4.9% (Fig 7A). NEU1 mRNA
expression after HRVI in nasal epithelial cells was reduced in children with asthmaas
Fig 3. Distribution of p-values within RIDMs and RIREs of asthmatics vs controls. Changes were identified for
individual CpG DNA methylation (A) and mRNA expression (B) between children with and without asthma, using
ANOVA. Representation of the HRVI-induced associated changes (Δ = HRVI-MOCK) of CpG DNA methylation and
mRNA expression change are shown in (C). The crosses display the16 targets with a HRVI-induced change in DNA
methylation (minimum-change 3%) and mRNA expression (minimum-change 0.1 RPKM). Red crosses represent the
changes in BAT3 and NEU1.
https://doi.org/10.1371/journal.pone.0205275.g003
Table 2. Up- and down-regulated pathways from RIDMs in nasal epithelial cells of asthmatics vs. controls.
Down-regulated pathways p value ES number of CpGs
Dorso ventral axis formation 0.002 -0.61 15
Focal adhesion 0.005 -0.37 130
ECM receptor interaction 0.008 -0.43 58
Adherens junction 0.009 -0.43 56
Notch signalling pathway 0.019 -0.45 36
Lysine degradation 0.035 -0.46 31
WNT signalling pathway 0.036 -0.35 97
Complement and coagulation Cascades 0.038 -0.43 35
Inositol phosphate metabolism 0.039 -0.47 25
Vibrio cholerae infection 0.047 -0.43 31
Up-regulated pathways
Olfactory transduction 0.002 0.24 76
ES–enrichment score
https://doi.org/10.1371/journal.pone.0205275.t002
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compared to controls (-1.07 RPKM, Fig 7B and 7C). The correlation between RIDM and RIRE
is displayed in Fig 7D. Within NEU1, 4 additional CpGs with HRVI-induced asthma-specific
DNA methylation modifications were found (Table 4), though these changes were less than
3% and were thus not further investigated. A multi-factorial analysis could not confirm any
involvement of these 4 CpGs in NEU1 mRNA expression regulation.
Fig 4. Genes with significant RIDM and RIRE in asthma vs control. Minimum-changes of 3% for DNA methylation
(DNA met) and of 0.1 RPKM for mRNA expression (RNA exp) were applied to identify HRVI-induced asthma-
specific modifications. HRVI-induced asthma-specific changes in DNA methylation (RIDM) and mRNA (RIRE)
expression were analysed by ANOVA (�). Linear models were applied to correlate Δ DNA met / Δ RNA exp values
(��).
https://doi.org/10.1371/journal.pone.0205275.g004
Table 3. Location and function of genes with RIDM (minimum-change 3%) and RIRE (minimum-change 0.1 RPKM) in nasal epithelial cells from children with
asthma.
Gene CpG Position Chromosome Intron/exon Function�
AGPAT1 cg02525705 6p21.32 chr6:32145146 Intron 1/6 transferase activity, enzyme converts lysophosphatidic acid into phosphatidic acid
BAT3 cg24890294 6p21.33 chr6:31617323 Exon 3/25 control of apoptosis
NEU1 cg05550349 6p21.33 chr6:31828980 Exon 3/6 lysosomal enzyme
ANAPC11 cg08119847 17q25.3 chr17:79853461 Intron 3/3 ubiquitin ligase or transferase activity
MGST3 cg09553581 1q24.1 chr1:165603690 Intron 1/5 glutathione transferase or peroxidase activity
CCT6A cg23839680 7p11.2 chr7:56118238 prior Exon 1 poly(A) RNA and unfolded protein binding
MICB cg20240154 6p21.33 chr6:31464981 Intron 1/4 antigen and natural killer cell lectin-like receptor binding
SMN1 cg04281426 5q13.2 chr5:69345099 prior Exon
1/7
protein and RNA binding
LOC442454 cg03897851 Xp11.21 chrX:56764294 Intron 2/2 unknown
KLHL8 cg03129732 4q22.1 chr4:88084298 Exon 10/10 substrate-specific adapter for ubiquitination and degradation of RAPSN (Receptor Associated
Protein of the Synapse)
SLC16A3 cg07012687 17q25.3 chr17:80195180 Exon 4/5 poly(A) RNA binding and transmembrane transporter activity
GP1BA cg07892449 17p13.2 chr17:4835627 Exon 1/2 Integrin alpha IIb beta3 signalling and thrombin receptor activity
DNAJC7 cg21219666 17q21.2 chr17:40166108 Intron 1/13 heat shock protein binding
VDAC2 cg20673929 10q22.2 chr10:76990994 Exon 11/11 nucleotide binding and voltage-gated anion channel activity
FBXO7 cg17197051 22q12.3 chr22:32870183 prior Exon
1/9
protein kinase binding and ubiquitin-protein transferase activity
TP53I3 cg22999525 2p23.3 chr2:24300821 Intron 4/4 protein homodimerization activity and transferase activity
� http://www.genecards.org/
https://doi.org/10.1371/journal.pone.0205275.t003
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Comparison of the ALLIANCE DNA methylation findings to the Inner
City Asthma Consortium
The differences in DNA methylation between children with and without asthma that were
found in our study were compared with the published data of the Inner City Asthma Consor-
tium [16]. In their dataset, Yang et al. identified asthma-specific basal DNA methylations in
nasal epithelial cells from children with (n = 66 children) and without asthma (n = 36 chil-
dren), using also the HumanMethylation450 BeadChip Kit and pyrosequencing. The CpGs
with most pronounced DNA methylation differences (asthma vs. control) as reported by Yang
et al. were compared to our dataset (ALLIANCE dataset). We identified 14 out of the 20 most
pronounced asthma-specific CpGs of the Inner City Asthma Consortium in our ALLIANCE
dataset with comparable DNA methylation differences (Table 5).
Discussion
This is, to our knowledge, the first time that HRVI-induced genome-wide differences in DNA
methylation and coupled gene expression have been analysed in primary paediatric airway epi-
thelial cells of asthmatics and controls. 471 CpGs were identified as having significant RIDM
coinciding with RIRE. Of these, 16 showed a change in DNA methylation of greater than 3%
which were accompanied by an mRNA expression change greater than 0.1 RPKM.
Fig 5. RIDM of cg24890294 in BAT3 in nasal epithelial cells of asthmatic and controls. Changes in DNA
methylation were detected with a HumanMethylation450 BeadChip Kit (A), verified by pyrosequencing (B), and
modified mRNA expression (ΔHRVI-MOCK) detected by RNA sequencing (C) and qPCR (D). The correlation
between change in DNA methylation of cg24890294 and change in mRNA expression of BAT3 (E). Crosses represent
children with asthma and the triangles represent controls.
https://doi.org/10.1371/journal.pone.0205275.g005
Table 4. CpGs with RIDM in BAT3 and NEU1 in children with asthma.
CpG Gene p value HRVI-induced Δ DNA met (%) change (asthma-control)
cg14661811 BAT3 0.0326 1.4
cg24890294 BAT3 0.0027 -3.4
cg26710858 BAT3 0.0492 -0.7
cg00890041 NEU1 0.0159 0.5
cg01427769 NEU1 0.0344 1.0
cg05550349 NEU1 0.0039 -4.9
cg16194451 NEU1 0.0251 1.4
cg19036153 NEU1 0.0493 1.0
https://doi.org/10.1371/journal.pone.0205275.t004
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A genome-wide DNA methylation study demonstrated that HRVI led to specific changes
in the levels of nasal cell DNA methylation in adult asthmatics compared with controls [17].
Consistent with the findings of this adult study, our study confirmed 17 out of the 27 HRVI-
induced DNA methylation modifications on gene level reported by McErlean et al. [17]. How-
ever, none of the CpGs and associated genes reported by McErlean et al. remained in the top
target list for this study, likely a result of the very stringent cut-offs for changes of DNA meth-
ylation and mRNA expression applied during the minimum-change-filtering process.
This study focused on genes with modified DNA methylation and mRNA expression in
response to a viral infection, and those previously reported to be important in asthma. In our
cohort, HRVI-induced BAT3 expression was reduced in children with asthma compared with
Fig 6. Linear model of cg24890294 and cg14661811 DNA methylation-dependent mRNA expression of BAT3.
Crosses represent the data points of children with asthma and the triangles represent those children without asthma
(r2 = 0.15 for the linear model).
https://doi.org/10.1371/journal.pone.0205275.g006
Fig 7. RIDM (cg05550349) and RIRE of NEU1 for asthmatics and controls. RIDM were detected with a
HumanMethylation450 BeadChip Kit (A) and RIRE was detected by mRNA sequencing (B) and qPCR (C). The
correlation between change in DNA methylation in cg05550349 with change in mRNA expression of NEU1 (D).
Crosses represent children with asthma and the triangles represent controls.
https://doi.org/10.1371/journal.pone.0205275.g007
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children without asthma. BAT3, also known as HLA-B-associated transcript 6 (BAG6),
encodes for a cytoplasmic protein which is involved in mammalian cell apoptosis and prolifer-
ation [18, 19]. BAT3 is also involved in the activation process of natural killer cells initiating
IFN-γ and TNF-α cytokine release [20, 21]. It is reported that airway epithelial cells of individ-
uals with asthma have a decreased ability to increase IFN-γ production during HRVI [22].
IFN-γ is central in the initiation of the anti-viral immune response [23]. The reported reduced
IFN-γ production by epithelial cells and potentially by natural killer cells in asthmatics, might
be a result of decreased BAT3 expression after HRVI, and could explain the increased suscepti-
bility of asthma patients to LRTIs [8].
Another gene identified in our study and involved in NK cell activation is MHC Class I
Polypeptide-Related Sequence B (MICB). MICB is reported to bind to the NKG2D receptor
[24–26]. MICB expression is in general increased after HRVI of airway epithelial cells. In
healthy individuals, sputum MICB is increased following HRVI, while this was not seen in
asthma. In healthy individuals with HRVI, the number of NK cells in the bronchoalveolar
lavage (BAL) positively correlated with serum MICB levels [27]. Our study showed MICB
mRNA expression to be increased during HRVI in children without asthma compared to the
children with asthma. This finding suggests increased NK cell activation as a possible cause of
the positive correlation of NK cells number and serum MICB previously reported in healthy
individuals during a HRVI [27].
A third gene with RIDM and RIRE was the catalytic enzyme Neuraminidase 1 (NEU1).
Katoh et al. showed that NEU1 plays a role in the T helper type 2 (Th2)-mediated airway
inflammation in a murine acute asthma model [28]. Katoh and colleagues demonstrate that
Table 5. Comparison of asthma-specific CpGs within the ALLIANCE dataset with the Inner City Asthma Consortium.
Gene CpG Chromosom Start Yang et.al. p value Yang et.al. Δ DNA met [%] ALLIANCE p value ALLIANCE Δ DNA met [%]
LDLRAD3 cg24656207 chr11 36030085–36030086 0.002895 -28.8 0.0009 -26.5
METTL1 cg20372759 chr12 58162286 2.12E-05 -27 0.0005 -23.1
LINC00703 cg03875819 chr10 4386801–4386802 2.28E-05 -26.1 n.s. -16.3
CDC45 cg02333649 chr22 19471092–19471093 4.13E-04 -24.4 0.0092 -17.3
C15orf54 cg10099207 chr15 39544143–39544144 0.01364 -22.9 0.0144 -24.9
DUOX1 cg13570892 chr15 45449436–45449437 6.83E-07 -22.7 n.s. -16.5
ZFPM1 cg04983687 chr16 88558222–88558223 1.43E-05 -29.5 n.s. 0.3
LDLRAD3 cg24656207 chr11 36030085–36030086 6.23E-06 -28.8 0.0009 -26.5
METTL1 cg20372759 chr12 58162286–58162287 5.03E-08 -27 0.0005 -23.1
LINC00703 cg03875819 chr10 4386801–4386802 5.03E-08 -26.1 n.s. -16.3
CDC45 cg02333649 chr22 19471092–19471093 8.17E-07 -24.4 0.0092 -17.3
SERPINB6 cg03668556 chr6 2977292–2977293 4.99E-04 -24.1 n.s. -22.9
C15orf54 cg10099207 chr15 39544143–39544144 2.62E-05 -22.9 0.0144 -24.9
Validation set Yang et al.
ALOX15 cg11609940 chr17 4541333–4541334 7.82E-04 -10.1 0.0093 -16.1
POSTN cg04922971 chr13 38172802–38172803 7.25E-04 -11.6 0.0459 -6.1
LDLRAD3 cg24656207 chr11 36030085–36030086 6.23E-06 -28.3 0.0009 -26.5
ATXN7L1 cg16027132 chr17 105521115–
05521116
4.09E-09 -27.3 0.0001 -37.9
METTL1 cg20372759 chr12 58162286–58162287 5.03E-08 -27 0.0005 -23.1
CCL5 cg02483931 chr17 34202460–34202461 0.017 1.9 n.s. 0.9
CTSC cg25636441 chr11 88059526–88059527 1.51E-03 -1.1 0.0044 -12.5
DNA met–DNA methylation, n.s.–not significant, Δ DNA met = asthma—control [%], ALLIANCE p value was determined by ANOVA model
https://doi.org/10.1371/journal.pone.0205275.t005
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the accumulation of Th2 cells was reduced in the airway of SM/J NEU1-knockout mice using a
Dermatophagoides farinae -induced model of asthma [28]. It has been reported, that NEU1
forms complexes with Toll Like Receptors (TLR2, 3, 4) and governs the activation of TLR sig-
nalling [29, 30]. TLR3 in lung epithelial cells recognizes RNA from HRV [31] and expression
is increased post-HRVI [32]. Furthermore, it was reported that blocking the TLR3 receptor in
lung epithelial cells leads to general increased IL-6, IL-8 and CCL-5 production [32]. This
implies that the failure of asthmatic airway cells to express NEU1 in response to HRVI would
result in limited TLR3 activation in those individuals compared to healthy subjects. As a result
of the limited TLR3 activation, cytokine expression in asthmatics would be above that of
healthy subjects when exposed to HRVI. IL-6 is increased in patients with asthma and is espe-
cially increased during asthma attacks [33, 34]. CCL5 mRNA expression in our data is
increased in children with asthma after HRVI (although this was not statistically significant,
p = 0.08), whereas an unremarkable increase was observed in children without asthma (Fig
8A). Our study is therefore supportive for this interaction, demonstrating a negative relation
between NEU1 and mRNA expression of IL6 (r2 = 0.11, p = 0.035) (Fig 8B).
This study has several strengths but also some limitations. Very strict filtering processes
and multiple verification steps were included to disentangle epigenetic effects in children with
and without asthma, adding strength to the target candidates identified. This approach allows
the creation of a valid dataset without a false discovery rate (FDR) correction of the generated
genome wide data analysis. Another strength of this study is the verification of the successful
HRVI within the cultures of primary nasal epithelial cells.
However, one limitation of this study was the use of primary cell cultures and, thus, an
inability to distinguish the impact of HRV-infected cells from the impact of uninfected and
indirectly responding cells (e.g. cytokines). To date, there have been no studies exploring these
two cell populations. Separation of infected cells with a fluorescence-activated cell sorting
based on increased ICAM1 expression [35] would allow further insight into the effect of HRVI
on changes of DNA methylation and related mRNA expression, however, large numbers of
cells are required for this technique, not feasible in a paediatric cohort. Also, single cell
sequencing analysis would generate an explicit understanding of HRV dependent modifica-
tions within direct infected or uninfected by-stander cells. Nevertheless, the reported results in
this study allow an insight into the potential role of HRVI-induced asthma-specific differences
in DNA methylation and altered mRNA expression. This experimental design may be more
representative of an in vivo HRVI where infected and uninfected cells are likely to be present
during an infection.
Fig 8. Increase of CCL5 production in children without asthma. Specific increase (A) and linear correlation of IL6
and NEU1 mRNA expression in nasal epithelial cells from children without asthma (r2 = 0.11) (B).
https://doi.org/10.1371/journal.pone.0205275.g008
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A second limitation of the study design was that we can only take a snapshot of the different
epigenetic changes in asthma and healthy children. Future longitudinal studies could assess
whether these reported RIDMs/RIREs are conserved and if those differences would increase
with repetitive infections over a lifetime. It was reported by Lopez-Souza et al. that nasal epi-
thelial cells were more resistant to HRVIs compared to bronchial epithelial cells, with viral rep-
lication being more effective in bronchial epithelial cells [36]. This might lead to the
assumption that the above identified genes could be subjected to further methylation in the
lung epithelium of children infected with virus. This scenario may pave the way for the possi-
bility that recurrent HRVI could predispose children for the development of asthma later in
life, or the worsening of asthma severity. Lastly, the sample size of our cohort was small and
the results will require verification in a larger cohort. However, the results of the top targets
were verified by an alternative analytical technique (qPCR and Pyrosequencing) and so we
expect that the presented results are reliable and representative.
Due to ethical constraints associated with the collection of bronchial epithelial cells from
children, the study used samples of the nasal epithelium to model the bronchial epithelium.
Bergougnoux et al. summarizes that nasal epithelial cells are a reliable model system to study
DNA methylation in diseases affecting the lower airway tract [37]. They concluded that in dif-
ferent diseased states, similar patterns of gene expression and modification are reflected in
nasal and bronchial epithelial cells. Additionally, the histological structure and cellular compo-
sition of the nasal and bronchial epithelium is similar [37]. To ensure epithelial-specific meth-
ylation is generated and retrieved, we confirmed the nasal epithelial cell cultures had a high
expression of typical epithelial cell marker mRNA [38, 39] and minimal mRNA expression of
typical fibroblasts markers (Fig 9) [40–42].
Fig 9. mRNA expression of cell markers. The epithelial cell markers Mucin 1 (MUC1), Cadherin 1 (CDH1), and
Claudin 1 (CLDN1) and the fibroblast markers Thy-1 Cell Surface Antigen (THY1), Actin Alpha 1 Skeletal Muscle
(ACTA1), and Atlastin GTPase 1 (ATL1) were measured to verify the homogeneity of the analysed nasal epithelial cell
cultures.
https://doi.org/10.1371/journal.pone.0205275.g009
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Notably, it should be mentioned that 8 of the 10 analysed asthmatic children are not steroid
native and the impact of ICS use on DNA methylation and the immune response against
HRVI could not be excluded.
Yang et al. showed evidence of asthma-specific DNA methylation in nasal epithelial cells
from asthmatics when compared to age-matched healthy subjects [16]. The comparison of the
asthma-specific single CpG methylations reported by Yang et al. and the MOCK-infected cells
in our study set confirmed 14 out of 20 asthma-specific CpGs in the asthma cohort. Also the
detected dimension of asthma-specific DNA methylation were comparable between both
cohorts for the identified CpGs. 10 of the 14 CpGs with asthma-specific DNA methylation
showed a decreased DNA methylation of more than 20% in both cohorts. The consistencies
between the 2 cohorts indicate that asthmatics show specific methylation patterns and consis-
tency of the datasets suggest that the findings of our study are representative of the asthma
population.
Jackson et al. reported that infant wheezing as a result of combined HRV and Respiratory
Syncytial Virus infections is a risk factor for asthma development at the age of 6 [5]. Future
experiments into viral-induced genomic modifications would benefit from including other
viruses such as Respiratory Syncytial Virus, Influenza virus and bacterial infection or coloniza-
tion associated with asthma [43, 44].
Conclusion
This pilot study is the first to report genome-wide DNA methylation and correlated mRNA
expression in the context of an asthma-specific HRVI response of nasal epithelial cells from
children. Stringent application of minimum-change-filtering and verification of identified
DNA methylation and mRNA expression findings allowed identification of asthma-specific
target genes like BAT3 and NEU1 and offers potential new avenues for patient stratification
and personalized therapy. Our data might contribute to a better understanding of the complex
relationship of early viral infections and development and/or progression of asthma. More-
over, these reported gene targets might have the potential for further applications in asthma
prevention or treatment. The promising findings of this pilot study would benefit from further
investigation in a lager patient cohort of children with and without asthma.
Supporting information
S1 Table. DNA Methylation valuse of the difference between HRVI and MOCK infection
for the CpGs in Genes with significant RIDM and RIRE in asthma vs control and a mini-
mum-change of 3% for DNA methylation and 0.1 RPKM for mRNA.
(TXT)
S2 Table. mRNA expression valuse of the difference between HRVI and MOCK infection
for the CpGs in Genes with significant RIDM and RIRE in asthma vs control and a mini-
mum-change of 3% for DNA methylation and 0.1 RPKM for mRNA.
(TXT)
Acknowledgments
The present work was enabled by the participants of the ALLIANCE cohort and members of
the ALLIANCE study group including the following scientists: Oliver Fuchs, Barbara Roesler,
Nils Welchering, Naschla Kohistani-Greif, Katja Landgraf-Rauf, Kristina Laubhahn, Nicole
Maison, Claudia Liebl, Bianca Schaub, Markus Ege, Erika von Mutius, Isabell Ricklef, Gesa
Diekmann, Laila Sultansei, Markus Weckmann, Matthias V Kopp, Gyde Nissen, Inke R.
Rhinovirus infections in children with asthma
PLOS ONE | https://doi.org/10.1371/journal.pone.0205275 November 28, 2018 15 / 18
Ko¨nig, Dominik Thiele, Thomas Bahmer, Anne-Marie Kirsten, Frauke Pedersen, Henrik
Watz, Benjamin Waschki, Klaus F. Rabe, Christian Herzmann, Annika Opitz, Karoline I.
Gaede, Peter Zabel, Folke Brinkmann, Anna-Maria Dittrich, Christine Happle, Ruth Grychtol,
Aydin Malik, Nicolaus Schwerk, Christian Dopfer, Mareike Price, Gesine Hansen, Michael
Zemlin, Matthias Mu¨ller, Ernst Rietschel, and Silke van Koningsbruggen-Rietschel. A special
thanks goes to the laboratory team at the University Medical Center Schleswig-Holstein which
organized and conducted the recruitment of the participants of the ALLIANCE cohort.
Members of the German Center of Lung Research (DZL) within the Airway Research Cen-
ter North (ARCN) are Martin Pech, Markus Weckmann, Isabell Ricklefs, Klaus Rabe and Mat-
thias V. Kopp. Members of the German Center of Lung Research (DZL) within the
Comprehensive Pneumology Center Munich (CPC-M) are Oliver Fuchs and Erika v. Mutius.
Gesine Hansen is a member of the German Center of Lung Research (DZL) within the Bio-
medical Research in Endstage and Obstructive Lung Disease Hannover (BREATH).
Author Contributions
Conceptualization: Martin Pech, Markus Weckmann, Matthias V. Kopp.
Data curation: Martin Pech, Inke R. Ko¨nig, Isabell Ricklefs.
Formal analysis: Martin Pech, Markus Weckmann, Inke R. Ko¨nig.
Funding acquisition: Markus Weckmann, Klaus Rabe, Gesine Hansen, Erika v. Mutius, Mat-
thias V. Kopp.
Methodology: Martin Pech, Markus Weckmann.
Project administration: Martin Pech, Markus Weckmann.
Resources: Markus Weckmann, Andre Franke, Femke-Anouska Heinsen, Brian Oliver, Isabell
Ricklefs, Oliver Fuchs, Matthias V. Kopp.
Software: Femke-Anouska Heinsen.
Supervision: Matthias V. Kopp.
Visualization: Martin Pech.
Writing – original draft: Martin Pech, Matthias V. Kopp.
Writing – review & editing: Markus Weckmann, Inke R. Ko¨nig, Andre Franke, Brian Oliver,
Klaus Rabe, Gesine Hansen, Erika v. Mutius, Matthias V. Kopp.
References
1. Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol.
2006; 6(11):869–74. https://doi.org/10.1038/nri1958 PMID: 17063187
2. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006; 355(21):2226–35. https://
doi.org/10.1056/NEJMra054308 PMID: 17124020
3. WHO. http://www.who.int/respiratory/asthma/en/. 2017.
4. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma preven-
tion and treatment. Nat med. 2012; 18(5):726–35. https://doi.org/10.1038/nm.2768 PMID: 22561836
5. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovi-
rus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med.
2008; 178(7):667–72. https://doi.org/10.1164/rccm.200802-309OC PMID: 18565953
6. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral
infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin
Immunol. 2007; 119(5):1105–10. https://doi.org/10.1016/j.jaci.2006.12.669 PMID: 17353039
Rhinovirus infections in children with asthma
PLOS ONE | https://doi.org/10.1371/journal.pone.0205275 November 28, 2018 16 / 18
7. Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Virol. 2010; 84(15):7418–26. https://doi.
org/10.1128/JVI.02290-09 PMID: 20375160
8. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, et al. Frequency, severity, and
duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.
Lancet. 2002; 359(9309):831–4. https://doi.org/10.1016/S0140-6736(02)07953-9 PMID: 11897281
9. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-
induced wheezing in infancy—the first sign of childhood asthma? J Allergy Clin Immunol. 2003; 111
(1):66–71. PMID: 12532098
10. Lemanske RF Jr., Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses dur-
ing infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005; 116(3):571–7.
https://doi.org/10.1016/j.jaci.2005.06.024 PMID: 16159626
11. van der Gugten AC, van der Zalm MM, Uiterwaal CS, Wilbrink B, Rossen JW, van der Ent CK. Human
rhinovirus and wheezing: short and long-term associations in children. Pediatr Infect Dis J. 2013; 32
(8):827–33. https://doi.org/10.1097/INF.0b013e318290620e PMID: 23584579
12. Miller EK, Edwards KM, Weinberg GA, Iwane MK, Griffin MR, Hall CB, et al. A novel group of rhinovi-
ruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009; 123(1):98–104 e1.
https://doi.org/10.1016/j.jaci.2008.10.007 PMID: 19027147
13. Iwasaki J, Smith WA, Khoo SK, Bizzintino J, Zhang G, Cox DW, et al. Comparison of rhinovirus antibody
titers in children with asthma exacerbations and species-specific rhinovirus infection. J Allergy Clin
Immunol. 2014; 134(1):25–32. https://doi.org/10.1016/j.jaci.2014.03.014 PMID: 24767874
14. Zardo G, Fazi F, Travaglini L, Nervi C. Dynamic and reversibility of heterochromatic gene silencing in
human disease. Cell res. 2005; 15(9):679–90. https://doi.org/10.1038/sj.cr.7290337 PMID: 16212874
15. The Global Asthma Network, The Global Asthma Report 2014. http://ginasthma.org/
16. Yang IV, Pedersen BS, Liu AH, O’Connor GT, Pillai D, Kattan M, et al. The nasal methylome and child-
hood atopic asthma. J Allergy Clin Immunol. 2017; 139(5):1478–88. https://doi.org/10.1016/j.jaci.2016.
07.036 PMID: 27745942
17. McErlean P, Favoreto S Jr., Costa FF, Shen J, Quraishi J, Biyasheva A, et al. Human rhinovirus infec-
tion causes different DNA methylation changes in nasal epithelial cells from healthy and asthmatic sub-
jects. BMC Med Genomics. 2014; 7:37. https://doi.org/10.1186/1755-8794-7-37 PMID: 24947756
18. Desmots F, Russell HR, Lee Y, Boyd K, McKinnon PJ. The reaper-binding protein scythe modulates
apoptosis and proliferation during mammalian development. Mol Cell Biol. 2005; 25(23):10329–37.
https://doi.org/10.1128/MCB.25.23.10329-10337.2005 PMID: 16287848
19. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. HLA-B-associated transcript 3 (Bat3)/
Scythe is essential for p300-mediated acetylation of p53. Genes Dev. 2007; 21(7):848–61. https://doi.
org/10.1101/gad.1534107 PMID: 17403783
20. Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, Nohroudi K, et al. Dendritic cells
release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One.
2008; 3(10):e3377. https://doi.org/10.1371/journal.pone.0003377 PMID: 18852879
21. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, et al.
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the
NKp30 receptor on natural killer cells. Immunity. 2007; 27(6):965–74. https://doi.org/10.1016/j.immuni.
2007.10.010 PMID: 18055229
22. Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, et al. Rhinovirus-induced lower
respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 produc-
tion. Proc Natl Acad Sci U S A. 2008; 105(36):13562–7. https://doi.org/10.1073/pnas.0804181105
PMID: 18768794
23. Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA. Interferon-gamma (IFN-gamma) down-regulates
the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epi-
thelial cells. Clin Exp Immunol. 1997; 110(3):362–9. https://doi.org/10.1046/j.1365-2249.1997.
4221440.x PMID: 9409637
24. Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, et al. Interactions of human NKG2D with its
ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics. 2001; 53
(4):279–87. PMID: 11491531
25. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al. ULBPs, novel MHC class
I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D
receptor. Immunity. 2001; 14(2):123–33. PMID: 11239445
26. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J, et al. Structure and function of major histocom-
patibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol
Immunol. 2002; 38(9):637–60. PMID: 11858820
Rhinovirus infections in children with asthma
PLOS ONE | https://doi.org/10.1371/journal.pone.0205275 November 28, 2018 17 / 18
27. Telcian AG, Zdrenghea MT, Caramori G, Laza-Stanca V, Message SD, Kebadze T, et al. Soluble major
histocompatibility complex class I-related chain B molecules are increased and correlate with clinical
outcomes during rhinovirus infection in healthy subjects. Chest. 2014; 146(1):32–40. https://doi.org/10.
1378/chest.13-2247 PMID: 24556715
28. Katoh S, Maeda S, Fukuoka H, Wada T, Moriya S, Mori A, et al. A crucial role of sialidase Neu1 in hya-
luronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute
asthmatic model. Clin Exp Immunol. 2010; 161(2):233–41. https://doi.org/10.1111/j.1365-2249.2010.
04165.x PMID: 20491786
29. Amith SR, Jayanth P, Finlay T, Franchuk S, Gilmour A, Abdulkhalek S, et al. Detection of Neu1 sialidase
activity in regulating Toll-like receptor activation. J Vis Exp. 2010(43).
30. Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, et al. Broad and direct interaction between TLR
and Siglec families of pattern recognition receptors and its regulation by Neu1. Elife. 2014; 3:e04066.
https://doi.org/10.7554/eLife.04066 PMID: 25187624
31. Triantafilou K, Vakakis E, Richer EA, Evans GL, Villiers JP, Triantafilou M. Human rhinovirus recogni-
tion in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-
inflammatory immune response. Virulence. 2011; 2(1):22–9. https://doi.org/10.4161/viru.2.1.13807
PMID: 21224721
32. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL. Toll-like receptor 3 is induced by
and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol.
2005; 79(19):12273–9. https://doi.org/10.1128/JVI.79.19.12273-12279.2005 PMID: 16160153
33. Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, et al. Elevation of IL-6 in the
allergic asthmatic airway is independent of inflammation but associates with loss of central airway func-
tion. Respir Res. 2010; 11:28. https://doi.org/10.1186/1465-9921-11-28 PMID: 20205953
34. Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, et al. Circulating interleukin-6 levels in
patients with bronchial asthma. Am J Respir Crit Care Med. 1995; 151(5):1354–8. https://doi.org/10.
1164/ajrccm.151.5.7735584 PMID: 7735584
35. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion
molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem. 1999; 274
(14):9707–20. PMID: 10092659
36. Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. In vitro susceptibility to rhinovi-
rus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy
Clin Immunol. 2009; 123(6):1384–90 e2. https://doi.org/10.1016/j.jaci.2009.03.010 PMID: 19428098
37. Bergougnoux A, Claustres M, De Sario A. Nasal epithelial cells: a tool to study DNA methylation in air-
way diseases. Epigenomics. 2015; 7(1):119–26. https://doi.org/10.2217/epi.14.65 PMID: 25687471
38. Forstner JF. Intestinal mucins in health and disease. Digestion. 1978; 17(3):234–63. https://doi.org/10.
1159/000198115 PMID: 25218
39. Aoyagi K, Minashi K, Igaki H, Tachimori Y, Nishimura T, Hokamura N, et al. Artificially induced epithe-
lial-mesenchymal transition in surgical subjects: its implications in clinical and basic cancer research.
PLoS One. 2011; 6(4):e18196. https://doi.org/10.1371/journal.pone.0018196 PMID: 21533028
40. Esterre P, Melin M, Serrar M, Grimaud JA. New specific markers of human and mouse fibroblasts. Cell
Mol Biol. 1992; 38(3):297–301. PMID: 1611660
41. Alt E, Yan Y, Gehmert S, Song YH, Altman A, Gehmert S, et al. Fibroblasts share mesenchymal pheno-
types with stem cells, but lack their differentiation and colony-forming potential. Biol Cell. 2011; 103
(4):197–208. https://doi.org/10.1042/BC20100117 PMID: 21332447
42. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characteri-
zation of a fibroblast marker: FSP1. J Cell Biol. 1995; 130(2):393–405. PMID: 7615639
43. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev
Microbiol. 2012; 10(7):459–71. https://doi.org/10.1038/nrmicro2801 PMID: 22669219
44. Sharma G, Sowpati DT, Singh P, Khan MZ, Ganji R, Upadhyay S, et al. Genome-wide non-CpG methyl-
ation of the host genome during M. tuberculosis infection. Sci Rep. 2016; 6:25006. https://doi.org/10.
1038/srep25006 PMID: 27112593
Rhinovirus infections in children with asthma
PLOS ONE | https://doi.org/10.1371/journal.pone.0205275 November 28, 2018 18 / 18
